Oncternal Therapeutics Overview
Oncternal Therapeutics Discounted Cash Flow
DCF Analysis for ONCT.
Get informed when a big investor buys or sells
+ FollowFair Value
$0.12
Current Fair Value
$0.12
↓ 77.7% Downside
Overvalued by 77.7% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison